Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People whose scans show findings consistent with lung cancer, or who have a small number of cancer spots in the lung that may have spread from another part of the body (any cancer type may be considered for the spreading cases).
• For primary lung cancer cases, the lung lesion must have a solid portion making up at least 50% of the total lesion on scans.
• People whose disease can be measured or assessed on scans according to standard criteria (called RECIST v1.1).
• People aged 18 years or older.
• People who are reasonably well and able to carry out daily activities, rated on a standard scale from 0 (fully active) to 2 (up and about more than half of waking hours) (confirm with trial site).
• People who could potentially become pregnant must have a negative pregnancy test (urine or blood) before joining the trial.
• People who could potentially become pregnant must agree to use adequate contraception (hormonal methods, barrier methods, or abstinence) from the time of signing consent, throughout the trial, and for 7 days after finishing treatment.
• People whose partner could become pregnant must agree to use adequate contraception from the time of signing consent, throughout the trial, and for 90 days after finishing treatment.
• People who are able to understand the trial and are willing to sign a written consent form before joining.

Who may not be able to join:

• People who have previously had radiation therapy in an area that would overlap with the treatment area planned in this trial.
• People with primary lung cancer where the lung lesion is entirely or mostly hazy (ground glass opacity) with no solid component on scans.
• People who are still experiencing significant side effects (rated grade 2 or higher) in the chest area from a previous cancer treatment, such as lung inflammation, airway problems, airway bleeding, or swallowing-tube irritation.
• People who are currently taking part in another clinical trial using an experimental treatment, or who are receiving certain chemotherapy drugs that damage DNA, at the same time as this trial.
• People who have another cancer (current or previous) whose disease or treatment could interfere with the safety or results of this trial.
• People with ongoing or active infections that require treatment through the bloodstream (such as IV antibiotics).
• People with unstable chest pain (unstable angina).
• People with stage 3 or more severe idiopathic pulmonary fibrosis (a serious scarring lung condition).
• People with an irregular heart rhythm (cardiac arrhythmia).
• People with mental health or personal circumstances that would make it difficult to follow the trial requirements.
• People with any other illness or condition that the treating doctor feels would affect their safety or the trial's results.
• People who are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.